Vivos Therapeutics, Inc.

VVOS · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$5-$5-$4-$3
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$0$1-$0-$0
Other Non-Cash$1$0$0$0
Operating Cash Flow-$4-$3-$4-$3
Investing Activities
PP&E Inv.$1-$1-$0-$0
Net Acquisitions$5-$5$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$6$0$0$0
Investing Cash Flow$0-$6-$0-$0
Financing Activities
Debt Repay.$0$10$0$0
Stock Issued$1$2$0$4
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$3$0$0-$0
Financing Cash Flow$3$11$0$3
Forex Effect$0$0$0$0
Net Chg. in Cash-$1$2-$4-$0
Supplemental Information
Beg. Cash$4$2$6$6
End Cash$3$4$2$6
Free Cash Flow-$3-$4-$4-$3
Vivos Therapeutics, Inc. (VVOS) Financial Statements & Key Stats | AlphaPilot